Carol Suh is the founder of Neumora Therapeutics. Neumora Therapeutics has raised $500M in total funding. Latest round: Series A.
Carol Suh is an investor in pharmaceuticals and biotechnology. She has invested in companies such as HI-Bio and Orbital Therapeutics. Public company materials for Neumora Therapeutics describe it as a clinical-stage biotechnology company focused on precision medicines for brain diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide